The genomic landscape of endocrine-resistant metastatic breast cancer

被引：0
|
作者：
Razavi, P. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-ES4-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ES4-3
引用
收藏
页数：1
相关论文
共 50 条
  • [21] PIK3CA mutations in endocrine-resistant breast cancer
    Schagerholm, Caroline
    Robertson, Stephanie
    Toosi, Hosein
    Sifakis, Emmanouil G.
    Hartman, Johan
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [22] Genomic Evolution of Endocrine-Resistant Breast Cancer Cell Lines Reveals Molecular Aberrations Consistent with Biological Phenotype
    Mancini, C. M.
    Ramos, P.
    Willis, A. L.
    Lewis-Wambi, J. S.
    Ariazi, E. A.
    Kim, H. R.
    Tapia, C.
    Bittner, M.
    Jordan, V. C.
    Cunliffe, H. E.
    CANCER RESEARCH, 2010, 70
  • [23] Epigenetic Reprogramming of HOXC10 in Endocrine-Resistant Breast Cancer
    Pathiraja, Thushangi N.
    Nayak, Shweta R.
    Xi, Yuanxin
    Jiang, Shiming
    Garee, Jason P.
    Edwards, Dean P.
    Lee, Adrian V.
    Chen, Jian
    Shea, Martin J.
    Santen, Richard J.
    Gannon, Frank
    Kangaspeska, Sara
    Jelinek, Jaroslav
    Issa, Jean-Pierre J.
    Richer, Jennifer K.
    Elias, Anthony
    McIlroy, Marie
    Young, Leonie S.
    Davidson, Nancy E.
    Schiff, Rachel
    Li, Wei
    Oesterreich, Steffi
    SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (229)
  • [24] Identification of a high FOXA1-induced pro-metastatic enhancer signature in endocrine-resistant and metastatic breast cancer
    Fu, Xiaoyong
    Pereira, Resel
    De Angelis, Carmine
    Nanda, Sarmistha
    Qin, Lanfang
    Veeraraghavan, Jamunarani
    Selenica, Pier
    Weigelt, Britta
    Reis-Filho, Jorge S.
    Nardone, Agostina
    Jeselsohn, Rinath
    Brown, Myles
    Rimawi, Mothaffar F.
    Osborne, Ckent
    Schiff, Rachel
    CANCER RESEARCH, 2020, 80 (04)
  • [25] Increased STAT1 Signaling in Endocrine-Resistant Breast Cancer
    Huang, Rui
    Faratian, Dana
    Sims, Andrew H.
    Wilson, Danielle
    Thomas, Jeremy S.
    Harrison, David J.
    Langdon, Simon P.
    PLOS ONE, 2014, 9 (04):
  • [26] PIK3CA mutations in endocrine-resistant breast cancer
    Schagerholm, C.
    Robertson, S.
    Holm, B.
    Awier, H.
    Toosi, H.
    Sifakis, E.
    Hartman, J.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S42 - S43
  • [27] Genomic Landscape and Endocrine-Resistant Subgroup in Estrogen Receptor-Positive, Progesterone Receptor-Negative, and HER2-Negative Breast Cancer
    Liu, Xi-Yu
    Ma, Ding
    Xu, Xiao-En
    Jin, Xi
    Yu, Ke-Da
    Jiang, Yi-Zhou
    Shao, Zhi-Ming
    THERANOSTICS, 2018, 8 (22): : 6386 - 6399
  • [28] Evolution of Cancer Stem-like Cells in Endocrine-Resistant Metastatic Breast Cancers Is Mediated by Stromal Microvesicles
    Sansone, Pasquale
    Berishaj, Marjan
    Rajasekhar, Vinagolu K.
    Ceccarelli, Claudio
    Chang, Qing
    Strillacci, Antonio
    Savini, Claudia
    Shapiro, Lauren
    Bowman, Robert L.
    Mastroleo, Chiara
    De Carolis, Sabrina
    Daly, Laura
    Benito-Martin, Alberto
    Perna, Fabiana
    Fabbri, Nicola
    Healey, John H.
    Spisni, Enzo
    Cricca, Monica
    Lyden, David
    Bonafe, Massimiliano
    Bromberg, Jacqueline
    CANCER RESEARCH, 2017, 77 (08) : 1927 - 1941
  • [29] Radiogenomic Landscape of Metastatic Endocrine-Positive Breast Cancer Resistant to Aromatase Inhibitors
    Khanyile, Richard
    Chipiti, Talent
    Hull, Rodney
    Dlamini, Zodwa
    CANCERS, 2025, 17 (05)
  • [30] Multiple endocrine-resistant breast cancer cell lines retain ER and sensitivity to endocrine therapy
    Gutgesell, Lauren M.
    Xiong, Rui
    Zhao, Jiong
    Zhao, Huiping
    Tonetti, Debra A.
    Thatcher, Gregory R.
    CANCER RESEARCH, 2018, 78 (13)
12345